Mutations of the CAPN3 gene encoding the muscle-specific calcium-activated neutral protease calpain-3, a proteolytic switch in muscle remodeling [9], cause LGMD2A, a MD with a wide clinical spectrum [10]. This evidence concerns the gene CAPN3 and autosomal recessive limb-girdle muscular dystrophy type 2A.